The Functional and Social Impact of TD on the Lives of Patients

Source: Tardive Dyskinesia Across Psychiatric Disorders
Diana Perkins, MD, MPH, and Martha Sajatovic, MD, discuss the functional and social impact of tardive dyskinesia on the lives of patients.

 

person default
Diana O. Perkins, MD, MPH
person default
Martha Sajatovic, MD
Released: January 11, 2022

In this episode, Diana Perkins, MD, MPH, and Martha Sajatovic, MD, discuss the impact of tardive dyskinesia on social and functional domains and the benefits of proper assessment and treatment of tardive dyskinesia in improving patient quality of life in these areas.

Information on this Educational Activity

Faculty

Diana O. Perkins, MD, MPH

Professor, Psychiatry
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

Diana O. Perkins, MD, MPH, has disclosed that she has received consulting fees from Karuna and other financial or material support from Alkermes.
Martha Sajatovic, MD

Professor of Psychiatry and of Neurology
Departments of Psychiatry and of Neurology
Case Western University School of Medicine
Director, Neurological and Behavioral Outcomes Center
Neurological Institute
University Hospitals of Cleveland
Cleveland, Ohio

Martha Sajatovic, MD, has disclosed that she has received funds for research support from Alkermes, Nuromate, and Otsuka and consulting fees from Alkermes, Janssen, Myriad, and Otsuka.

Program Medium

This program has been made available online.

Acknowledgements

Provided by Clinical Care Options, LLC
Contact Info

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant provided by
Neurocrine Biosciences, Inc.

Related Content

Board-certified psychiatric pharmacist provides information on the pharmacokinetics and administration of long-acting injectable antipsychotics, from Clinical Care Options (CCO)

Austin Campbell, PharmD, BCCP Released: January 24, 2023

In this on-demand webcast, an expert faculty explores updates on identifying and managing tardive dyskinesia.

Leslie Citrome, MD, MPH Physicians: maximum of 1.0 AMA PRA Category 1 Credit™ Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Physician Assistants: 1.0 AAPA Category 1 CME Credit Psychologists: 1.0 APA CE Credit Social Workers: 1.0 ACE CE Credit Released: January 23, 2023 Expired: January 22, 2024

In this on-demand webcast, an expert faculty describes the current and emerging treatment options for major depression

Greg W. Mattingly, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit™ Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Physician Assistants: 1.0 AAPA Category 1 CME Credit Psychologists: 1.0 APA CE Credit Social Workers: 1.0 ACE CE Credit Released: January 20, 2023 Expired: January 19, 2024

Two psychiatrists discuss the clinical use of long-acting injectable antipsychotics, from Clinical Care Options (CCO)

Leslie Citrome, MD, MPH person default Adam Lowy, MD Released: January 18, 2023

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings